Primary Image

Bionic Arm

Clinical Trial

Learning Robotic Arm Control with a Body-Machine Interface

IRB Protocol Number STU00210069

Contact

Andrew Thompson athompson@sralab.org

Objective

The Shirley Ryan 小恩雅 is conducting a research study that will evaluate how people learn to fully control a robotic arm using a body-machine interface.

We need participants with (ref: injured) and without (ref: uninjured) past spinal cord injuries. Injured participants have no history of neuromotor impairments or any other conditions that affect arm, shoulder, or upper trunk mobility.

We are investigating a new approach for learning the control of assistive devices with a body-machine interface, for individuals with spinal cord injuries. Your participation will be used to evaluate whether this approach can improve the control of assistive devices, such as robotic arms by individuals with spinal cord injuries.

Participants in this study will:

  • Operate a simulated and/or robotic arm to perform common daily tasks using arms and/or shoulders.
  • Answer questionnaires about the tasks performed.

The study length will be 15 sessions, lasting 2 hours each, over approximately 2 months (3 sessions per week).

For more information, please contact Andrew Thompson at athompson@sralab.org or Fiona Neylon at fneylon@sralab.org.

Who Can Participate

  • Ages 18+ (uninjured), 16+ (injured)
  • Able to give informed signed consent

Compensation

Participants will receive a stipend per session.

Age Range

Ages 18+ (uninjured), 16+ (injured)

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies

Brain-Based and Clinical Phenotyping of Pain Pharmacotherapy in Knee Osteoarthritis (PREDICT)

This is a clinical trial of people who have pain due to knee osteoarthritis at Northwestern University Feinberg School of Medicine in collaboration with Shirley Ryan 小恩雅. The study will last for about 20 weeks. 180 qualified participants will be randomly assigned in a 1:1:1 ratio (60 participants per group) to one of three treatment groups: duloxetine, celecoxib or placebo. Participants will have an X-ray, knee MRI, brain MRI, blood draws, pain sensitivity testing and will be asked to fill out questionnaires. The purpose of this study is to predict which participants will respond to the treatment.

read more
view all

Latest Updates

view all